Mar***.D.

CEO and President

学歴

University of California, San Francisco - School of Medicine

University of California, San Francisco - School of Medicine (1983 - 1990)

  • Degree: Doctor of Medicine (M.D.)
  • Field of Study: Unknown Field
  • Description:

University of California, San Francisco - School of Medicine (1983 - 1988)

  • Degree: Doctor of Philosophy (Ph.D.)
  • Field of Study: Microbiology and Immunology
  • Description:

Princeton University (1979 - 1983)

  • Degree: A.B.
  • Field of Study: Biology
  • Description:

スキル:

職務経験:

CEO and President at REVOLUTION Medicines

  • Location: San Francisco
  • Duration: 2014-11 to Present
  • Description:

Venture Partner at Third Rock Ventures

  • Location: San Francisco and Boston
  • Duration: 2012-03 to Present
  • Description: Venture Partner, 2012-2013 and 2015-present Partner, 2013-2015 CEO, Global Blood Therapeutics, 2012-2014 CEO, Nurix, 2012-2014

Executive Chairman at Constellation Pharmaceuticals

  • Location: Cambridge, MA
  • Duration: 2012-03 to Present
  • Description:

Chief Executive Officer at Constellation Pharmaceuticals

  • Location: Cambridge, MA
  • Duration: 2009-06 to 2012-03
  • Description:
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment Gap | Industry Consistency | Tenure Stability | Education-Career MatchLow

There are no evident employment gaps; all roles are in biotech/pharma with overlapping, continuous activity. The career demonstrates consistent industry focus, strong leadership tenure across multiple firms, and an education-to-career alignment suitable for executive biotech leadership.

Employment Gap | Industry Consistency | Tenure Stability | Education-Career MatchLow

Industry stability is high, with all positions in biotechnology and therapeutics. Tenure stability is generally strong, though early 2010s show overlapping CEO roles at multiple companies, which is common in biotech leadership; current long tenure at Revolution Medicines supports stability.

Employment Gap | Industry Consistency | Tenure Stability | Education-Career MatchMedium

Early 2010s show concurrent leadership roles (CEO of multiple companies and venture leadership) which could raise questions about bandwidth or aligned commitment to a single firm long-term; however, this is contextual in biotech entrepreneurship and is followed by sustained tenure at Revolution Medicines.

Employment Gap | Industry Consistency | Tenure Stability | Education-Career MatchLow

Education aligns with career trajectory (MD/PhD from UCSF School of Medicine supports high-level biopharma leadership) and complements his executive track record.

キャリア成長カーブ

Chief Executive Officer Entry
Constellation Pharmaceuticals
2009-06 to 2012-03
Executive Chairman ↑ 昇進
Constellation Pharmaceuticals
2012-03 to Present
Venture Partner Lateral
Third Rock Ventures
2012-03 to Present
CEO Entry
Global Blood Therapeutics
2012-2014
CEO Entry
Nurix
2012-2014
CEO and President Entry
REVOLUTION Medicines
2014-11 to Present
評価:The candidate exhibits a clear upward trajectory characterized by multiple CEO roles at biotech startups, governance leadership, and a pivotal venture capital position. This mix supports readiness for another senior executive opportunity at a growth-stage biotech or a high-impact board/venture leadership role.

最適な役職(トップ5)

1

Chief Executive Officer (CEO), Biotechnology Company98% 適合

Proven track record of leading multiple biotech firms, scaling operations, and attracting capital; well-suited for growth-stage to late-stage biopharma companies seeking transformative leadership.

2

Executive Chairman / Chair, Biotechnology Company92% 適合

Extensive governance experience with a history of guiding strategy at the board level while maintaining executive oversight; ideal for boards seeking seasoned leadership alongside CEO responsibilities.

3

General Partner / Managing Director, Biotech-focused Venture Capital90% 適合

Direct venture investing and firm-building background with Third Rock Ventures; strong ability to source deals, advise portfolio companies, and secure strategic funding.

4

Chief Operating Officer (COO), Biotechnology Company84% 適合

Operational scale across R&D, manufacturing, and potential commercialization; suitable for a company seeking integrated execution and growth operations.

5

Independent Director / Board Member, Biotechnology82% 適合

Widely respected industry leader with governance and strategic insight; adds credibility and risk oversight for company boards.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保